New drug cocktail tested to shrink tumors before esophageal cancer surgery
NCT ID NCT07374003
Summary
This study is testing a combination of two immunotherapy drugs with two chemotherapy drugs as a treatment given before surgery for locally advanced esophageal cancer. The goal is to see if this 'neoadjuvant' approach can shrink or even eliminate the tumor, making surgery more effective and improving long-term outcomes. The trial will enroll 62 patients to measure how many achieve a complete disappearance of cancer cells in the removed tissue and to monitor safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED, RESECTABLE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sub-i
Guangdong, GUANGZHOU, 510000, China
Conditions
Explore the condition pages connected to this study.